Researchers from the Max Planck Institute of Immunobiology and Epigenetics in Freiburg and ETH Zurich have created the first integrated map detailing the metabolic and molecular changes in human blood ...

New foundational AI models are accelerating advancements in biomedical research, according to a speaker at Cleveland Clinic’s ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...

A new study led by FAMU-FSU College of Engineering researchers investigating precision polymer blends revealed critical ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Sur180 Therapeutics, a biomedical startup supported by the Ponce Research Institute at Ponce Health Sciences University, has received a $2.38 million Phase II Small Business Innovation Research grant ...

We are very pleased to receive the continued funding under the OTA with BARDA to support the development of our antifungal drug candidates fosmanogepix and BAL2062. Both compounds offer a novel ...

The NIH will no longer accept grant applications that solely use animal testing models, instead requiring applicants to use AI models for human outcomes.

The global silanes market is traditionally viewed through the lens of its dominant end-use sectors—automotive, construction, ...

Four doctoral students in the Buffalo Neuroimaging Analysis Center (BNAC) recently received significant research awards.